Evidence map›Paper›PMID 36386814›Full record

ArticleFrontiers in genetics2022

The expression of apoptosis related genes in HK-2 cells overexpressing

Li Zhang, Xiaohong Sang, Yuanyuan Han, Alpati Abulitibu, Mufunayi Elken, Zhijie Mao, Shaotao Kang, Wenjun Yang, Chen Lu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Li ZhangNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Xiaohong SangNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Yuanyuan HanNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Alpati AbulitibuNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Mufunayi ElkenNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Zhijie MaoNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Shaotao KangNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Wenjun YangNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Chen LuNephrology Center of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
National Clinical Research Center for Digestive Diseases · CNXinjiang Medical University · CNFirst Affiliated Hospital of Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a serious disease that endangers human health. It is reported that inhibiting renal cell apoptosis can delay the progress of CKD. Our previous study found that the mice with protein phosphatase Mg2+/Mn2+ dependent 1K (

Indexed as

apoptosisenrichment analysishuman kidney-2 cellPPM1KRNA-seqtranscriptome

Identifiers

PMID36386814
PMCPMC9663473
OpenAlexW4308005206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.